1990

aap Ahrens, Ahrens & Partner GmbH & Co. Betriebs KG founded as an MBO of parts of the Johnson & Johnson Group subsidiary Mecron

1992

Market launch of innovative hex wrench screwdriver and recoil-cushioned hammer products

Innovative aap add-ons to a range of classic standard products such as the Orthner screw or the Samii-Zink screw for the spinal column

1995

Development of the Biorigid Nail™ Tibia, a virtually fracture-proof locked intramedullary nail system for the treatment of bone fractures that has been patented in many European countries and the United States.

Development of the AcroPlate™, an implant for defects in the shoulder joint

1997

Company conversion, now aap Implantate AG

Improved self-drilling and self-tapping properties establish a new generation of cannulated screws in the market

Export sales growth of more than 60%

1998

Biorigid Nail™ Femur as a result of further development of the groove locking principle

Certification of aap as an environmentally compatible manufacturer

US subsidiary aap Implants, Inc. founded in Plymouth, MA

Exclusive sales agreement concluded with a sales partner in Japan

1999

In-house developments make up 20% of total aap sales revenues

Sales approval for aap products in Japan

First biomedical technology company listed on the Frankfurt stock exchange in the Neuer Markt segment

Sales agreements signed with US companies

Exclusive sales agreement signed with a partner in the People’s Republic of China

Largest development contract (worth DM 5.9 m) in the company’s history

2000

Acquisition of the Mebio/Coripharm group of companies and a shareholding in Osartis GmbH & Co. KG to set up and develop a biomaterials division

Market launch of a new kind of trauma shoulder system and innovative femur system

Exclusive sales agreement for the US market signed with Exactech Inc.

Strategic participation in GEOT mbH

SDA sales approval for the Chinese market

2001

Market launch of VersaBond™ bone cement, Cerabone® bone replacement material and EASYMIX® cementing system

Exclusive sales agreement for all European markets with Essex Chemie AG for the EASYMIX® vacuum cementing system

Restructuring program initiated

2002

CE approvals for innovative bone replacement materials Ostim® and Cerabone® granules

Market launch of Ostim® bone matrix for bone regeneration

European sales approval for the entire knee endoprosthetics segment

License agreement signed for AEQUOS® knee endoprosthesis

Trauma Shoulder System is granted US patent

FDA approval of Biorigid Femur Nail with Condy-Lock™

2003

European approval of innovative synthetic bone replacement material PerOssal®

2004

Launch of VarioFit® hip endoprosthesis

Approval of VERSABOND™ AB bone cement by S&N in Europe and the United States

US subsidiary aap Implants, Inc. wound up

Merger of subsidiary Mebio with aap Implantate AG as symbolized by the new aap • mebio word/image mark

Capital increase and financial reorganization

2005

Total aquisition of Osartis

Aquisition of ADC Advanced Dental Care

Conclusion of a distributorship agreement with Biomet

2006

Signing the agreement to take over the Dutch Fame Group

2007

Integration of aap bio implants Netherlands B.V.,

Conclusion of contracts with Medtronics,

Zimmer & Wright Medical

2008

aap still specialist for Trauma, Orthopaedics and Biomaterials